---
title: What is the role of alpha-1 antitrypsin in the management of acute graft versus
  host disease?
date: '2024-12-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39709788/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&fc=20220919201732&ff=20241223171041&v=2.18.0.post9+e462414
source: (stem cell transplantation) AND (Cytomegalovirus pneumonia)
description: 'CONCLUSION: In conclusion, alpha-1 antitrypsin is an effective and safe
  treatment option in patients with SR-aGVHD, with response rates of up to 70 % in
  patients with skin, liver and gastrointestinal system involvement. Larger studies
  are needed to establish a standard second and subsequent treatment approach in patients
  with ...'
disable_comments: true
---
CONCLUSION: In conclusion, alpha-1 antitrypsin is an effective and safe treatment option in patients with SR-aGVHD, with response rates of up to 70 % in patients with skin, liver and gastrointestinal system involvement. Larger studies are needed to establish a standard second and subsequent treatment approach in patients with ...